山东医药

参考文献

[1]HAVERVALL S,ROSELL A,PHILLIPSON M,et al.Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers[J].Jama,2021,325(19):2015-2016.

[2]HUANG C,HUANG L,WANG Y,et al.6-month consequences of COVID-19 in patients discharged from hospital:a cohort study[J].Lancet,2021,397(10270):220-232.

[3]DESAI A D,LAVELLE M,BOURSIQUOT B C,et al.Longterm complications of COVID-19[J].Am J Physiol Cell Physiol,2022,322(1):C 1-C11.

[4]CARES-MARAMBIO K,MONTENEGRO-JIMéNEZ Y,TOR-RES-CASTRO R,et al.Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease2019 (COVID-19):a systematic review and meta-analysis[J].Chron Respir Dis,2021,18:14799731211002240.

[5]CARFìA,BERNABEI R,LANDI F.Persistent symptoms in patients after acute COVID-19[J].Jama,2020,324(6):603-605.

[6]LIANG L,YANG B,JIANG N,et al.Three-month follow-up study of survivors of coronavirus disease 2019 after discharge[J].J Korean Med Sci,2020,35(47):e418.

[7]MARTIN-VILLARES C,PEREZ MOLINA-RAMIREZ C,BAR-TOLOME-BENITO M,et al.Outcome of 1890 tracheostomies for critical COVID-19 patients:a national cohort study in Spain[J].Eur Arch Otorhinolaryngol,2021,278(5):1605-1612.

[8]SOLOMON J J,HEYMAN B,KO J P,et al.CT of Post-Acute Lung Complications of COVID-19[J].Radiology,2021,301(2):e383-e395.

[9]TABATABAEI S M H,RAJEBI H,MOGHADDAS F,et al.Chest CT in COVID-19 pneumonia:what are the findings in midterm follow-up[J].Emerg Radiol,2020,27(6):711-719.

[10]LIU C,YE L,XIA R,et al.Chest computed tomography and clinical follow-up of discharged patients with COVID-19 in Wenzhou city,Zhejiang,China[J].Ann Am Thorac Soc,2020,17(10):1231-1237.

[11]VAN GASSEL R J J,BELS J L M,RAAFS A,et al.High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19[J].Am JRespir Crit Care Med,2021,203(3):371-374.

[12]HUANG Y,TAN C,WU J,et al.Impact of coronavirus disease2019 on pulmonary function in early convalescence phase[J].Respir Res,2020,21(1):163.

[13]LONG B,BRADY W J,KOYFMAN A,et al.Cardiovascular complications in COVID-19[J].Am J Emerg Med,2020,38(7):1504-1507.

[14]XIE Y,XU E,BOWE B,et al.Long-term cardiovascular outcomes of COVID-19[J].Nat Med,2022,28(3):583-590.

[15]SIRIPANTHONG B,NAZARIAN S,MUSER D,et al.Recognizing COVID-19-related myocarditis:the possible pathophysiology and proposed guideline for diagnosis and management[J].Heart Rhythm,2020,17(9):1463-1471.

[16]ZENG J H,LIU Y X,YUAN J,et al.First case of COVID-19complicated with fulminant myocarditis:a case report and insights[J].Infection,2020,48(5):773-777.

[17]NISHIGA M,WANG D W,HAN Y,et al.COVID-19 and cardiovascular disease:from basic mechanisms to clinical perspectives[J].Nat Rev Cardiol,2020,17(9):543-558.

[18]MAO L,JIN H,WANG M,et al.Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan,China[J].JAMA Neurol,2020,77(6):683-690.

[19]CARONNA E,BALLVéA,LLAURADóA,et al.Headache:a striking prodromal and persistent symptom,predictive of COVID-19 clinical evolution[J].Cephalalgia,2020,40(13):1410-1421.

[20]MACCARONE M C,MAGRO G,TOGNOLO L,et al.Post CO-VID-19 persistent fatigue:a proposal for rehabilitative interventions in the spa setting[J].Int J Biometeorol,2021,65(12):2241-2243.

[21]MANTOVANI E,MARIOTTO S,GABBIANI D,et al.Chronic fatigue syndrome:an emerging sequela in COVID-19 survivors[J].J Neurovirol,2021,27(4):631-637.

[22]AHMED H,PATEL K,GREENWOOD D C,et al.Long-term clinical outcomes in survivors of severe acute respiratory syndrome and middle east respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission:a systematic review and meta-analysis[J].J Rehabil Med,2020,52(5):jrm00063.

[23]PASQUINI J,MAREMMANI C,SALVADORI S,et al.Testing olfactory dysfunction in acute and recovered COVID-19 patients:a single center study in Italy[J].Neurol Sci,2021,42(6):2183-2189.

[24]LECHIEN J R,DUCARME M,PLACE S,et al.Objective olfactory findings in hospitalized severe COVID-19 patients[J].Pathogens,2020,9(8):627

[25]YAN C H,FARAJI F,PRAJAPATI D P,et al.Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms[J].Int Forum Allergy Rhinol,2020,10(7):806-813.

[26]SWEID A,HAMMOUD B,BEKELIS K,et al.Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019[J].Int J Stroke,2020,15(7):733-742.

[27]YAGHI S,ISHIDA K,TORRES J,et al.SARS-Co V-2 and Stroke in a New York Healthcare System[J].Stroke,2020,51(7):2002-2011.

[28]BEYROUTI R,ADAMS M E,BENJAMIN L,et al.Characteristics of ischaemic stroke associated with COVID-19[J].J Neurol Neurosurg Psychiatry,2020,91(8):889-891.

[29]LEOW M K,KWEK D S,NG A W,et al.Hypocortisolism in survivors of severe acute respiratory syndrome (SARS)[J].Clin Endocrinol,2005,63(2):197-202.

[30]LAZARTIGUES E,QADIR M M F,MAUVAIS-JARVIS F.Endocrine significance of SARS-Co V-2's reliance on ACE2[J].Endocrinology,2020,161(9):bqaa108.

[31]MARAZUELA M,GIUSTINA A,PUIG-DOMINGO M.Endocrine and metabolic aspects of the COVID-19 pandemic[J].Rev Endocr Metab Disord,2020,21(4):495-507.

[32]GALLUS R,MELIS A,RIZZO D,et al.Audiovestibular symptoms and sequelae in COVID-19 patients[J].J Vestib Res,2021,31(5):381-387.

[33]HOGG E S,HAMPTON T,STREET I,et al.Increased incidence of idiopathic paediatric facial palsy during the coronavirus disease 2019 pandemic[J].J Laryngol Otol,2021,135(8):668-670.

[34]MAZZA M G,DE LORENZO R,CONTE C,et al.Anxiety and depression in COVID-19 survivors:Role of inflammatory and clinical predictors[J].Brain Behav Immun,2020.89:594-600.

[35]TAQUET M,LUCIANO S,GEDDES J R,et al.Bidirectional associations between COVID-19 and psychiatric disorder:retrospective cohort studies of 62 354 COVID-19 cases in the USA[J].Lancet Psychiatry,2021,8(2):130-140.

[36]CHAN L,CHAUDHARY K,SAHA A,et al.AKI in Hospitalized Patients with COVID-19[J].J Am Soc Nephrol,2021,32(1):151-160.

[37]鲁杨，陈琳，顾吉娜，等."长新冠"综合征的研究进展[J].中华医院感染学杂志，2022,32(16):2556-2560

[38]BHATIA R,SRIVASTAVA M V P.COVID-19 and stroke:incidental,triggered or causative[J].Ann Indian Acad Neurol,2020,23(3):318-324.

[39]SACHDEVA M,GIANOTTI R,SHAH M,et al.Cutaneous manifestations of COVID-19:report of three cases and a review of literature[J].J Dermatol Sci,2020,98(2):75-81.

[40]ROSSI A,MAGRI F,SERNICOLA A,et al.Telogen effluvium after SARS-Co V-2 infection:a series of cases and possible pathogenetic mechanisms[J].Skin Appendage Disord,2021,21(5):1-5.

[41]ROGERS J P,CHESNEY E,OLIVER D,et al.Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections:a systematic review and meta-analysis with comparison to the COVID-19 pandemic[J].Lancet Psychiatry,2020,7(7):611-627.